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Abstract 
Introduction. The incidence of cancer among residents in sites contaminated by pollut-
ants with a possible health impact is not adequately studied. In Italy, SENTIERI Project 
(Epidemiological study of residents in National Priority Contaminated Sites, NPCSs) 
was implemented to study major health outcomes for residents in 44 NPCSs.
Methods. The Italian Association of Cancer Registries (AIRTUM) records cancer inci-
dence in 23 NPCSs. For each NPCSs, the incidence of all malignant cancers combined 
and 35 cancer sites (coded according to ICD-10), was analysed (1996-2005). The ob-
served cases were compared to the expected based on age (5-year period,18 classes), 
gender, calendar period (1996-2000; 2001-2005), geographical area (North-Centre and 
Centre-South) and cancer sites specific rates. Standardized Incidence Ratios (SIR) with 
90% Confidence Intervals were computed.
Results. In both genders an excess was observed for overall cancer incidence (9% in men 
and 7% in women) as well as for specific cancer sites (colon and rectum, liver, gallblad-
der, pancreas, lung, skin melanoma, bladder and Non Hodgkin lymphoma). Deficits 
were observed for gastric cancer in both genders, chronic lymphoid leukemia (men), 
malignant thyroid neoplasms, corpus uteri and connective and soft-tissue tumours and 
sarcomas (women).
Discussion. This report is, to our knowledge, the first one on cancer risk of residents in 
NPCSs. The study, although not aiming to estimate the cancer burden attributable to 
the environment as compared to occupation or life-style, supports the credibility of an 
etiologic role of environmental exposures in contaminated sites. Ongoing analyses focus 
on the interpretation of risk factors for excesses of specific cancer types overall and in 
specific NPCSs in relation to the presence of carcinogenic pollutants.
INTRODUCTION
According to WHO contaminated sites are “areas 
hosting or having hosted human activities which have 
produced or might produce environmental contami-
nation of soil, surface or groundwater, air, food-chain, 
resulting or being able to result in human health im-
pacts” [1]. About 127 000 sites have been identified as 
contaminated in 33 European countries [2], a legacy of 
early industrialization and poor management practices.
Characterizing the health impact of contaminated sites 
involves a multidisciplinary approach, with a relevant role 
of epidemiology both in the analysis and evolving pattern 
of the health profiles of populations, and in the study of 
the associations between environmental exposures and 
health effects, according to specific hypotheses [1].
Protecting human health from exposure to environ-
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mental pollutants is a public health priority, but the 
burden of tumours among residents in areas contami-
nated by carcinogens is not adequately studied and 
the specific epidemiological literature on cancer risk in 
polluted areas is limited. In Italy, SENTIERI Project 
(Epidemiological study of residents in National Prior-
ity Contaminated Sites, NPCSs), funded by the Italian 
Ministry of Health, studied mortality among residents 
of 44 NPCSs included in the “National Environmental 
Remediation Programme” [3, 4].
The original feature of SENTIERI Project is the a 
priori evaluation of the epidemiological evidence on 
the causal association between 63 causes of death and 
residence in proximity of environmental sources of 
emission/release (chemical industries, petrochemicals 
and refineries, steel plants, power plants, mines and/
or quarries, harbour areas, asbestos or other mineral 
fibres, landfills and incinerators). The evaluation, based 
on standardized methodology [3, 4] was carried out 
to minimize the risk for researchers to be data-driven 
when interpreting results. Results of mortality analyses 
were published for each NPCS and for all 44 NPCSs 
combined [5]. In the period 1995-2002 for a total of 
403 692 deaths (men and women combined), an excess 
of 9969 deaths was observed, 4309 out of 9969 excess 
cases were from cancer deaths. 
A recent development of SENTIERI Project is the 
study of cancer incidence in NPCSs served by cancer 
registries. As compared to mortality, cancer incidence 
allows to investigate shorter latency periods, is mainly 
based on pathologically confirmed data not influenced 
by differential survival rates possibly related to socio-
economic deprivation, it accounts also for non lethal 
neoplasms. The Italian Association of Cancer Regis-
tries (AIRTUM, www.registri-tumori.it) records cancer 
incidence through population-based cancer registries. 
AIRTUM data are included in Cancer incidence in five 
continents published by the International Agency for 
Research on Cancer [6]. AIRTUM, funded by the Ital-
ian Ministry of Health, is involved in national [7] and 
international scientific collaborations [8].
The aim of the present study is to describe cancer in-
cidence in populations living in NPCSs, as compared to 
populations not residing in these areas, thus integrating the 
previously reported cancer mortality data [4, 5]. Cancer in-
cidence in all NPCSs combined is presented in this paper.
METHODS
Italian NPCSs mainly include industrial sites charac-
terized by the presence of chemical, petrochemical and 
steel industries, toxic waste dump sites and sites con-
taminated by asbestos and fluoro-edenite fibres [9, 10]. 
AIRTUM cancer registries are active in 23 out of 44 
NPCSs included in SENTIERI Project: 17 covering all 
age classes and six specialised in childhood cancer (0-19 
years). The present investigation includes more than 2 
000 000 people living in 23 NPCSs.
For each NPCSs, the incidence of all malignant can-
cers combined and 35 cancer sites, or groups of cancer 
sites, was computed. Cancer cases were coded accord-
ing to the 10th International Classification of Diseases 
(ICD-10). Figure 1 shows, for the 23 NPCSs, the geo-
NPCS Registry population 
NPCS
population 
in AIRTUM 
database N. 
NPCS
population 
in AIRTUM
database (%) 
Period of 
Registry 
activity
1 * 4388 963 16 1996-2005
2 * 4488 1 114 17 1996-2005
3 * 57 874 13 399 15 1996-2005
4 * 5300 1 458 16 1996-2005
5 * 10 066 2 210 6 1996-2005
6 98 724 20 933 100 1996-2004
7 485 287 209 057 100 1999-2001, 2004-2005
8 189 168 59 905 100 1999-2004
9 453 346 104 029 100 1996-2005
10 498 488 116 298 100 1996-2005
11 149 704 32 040 100 1996-2005
12 1 005 201 205 535 100 1996-2005
13 1 316 195 270 884 100 1996-2005
14 202 337 46 247 100 1996-2005
15 505 706 117 863 100 1996-2005
16 * 22 784 4689 17 1996-2005
17 ** 205 779 65 793 65 1996-2005
18 505 025 113 324 100 1996-2005
19 1 231 413 266 231 19 1996-2005
20 66 632 46 306 100 2003-2005
21 33 381 23 947 100 2003-2005
22 624 360 183 841 100 1999-2005
23 688 675 153 225 100 1996-2005
TOT. 3 409 131 2 059 291  
Figure 1
Italian National Priority Contaminated Sites: 
geographical distribution and main characteristics.
* childhood cancer registration
** adult and childhood cancer registration
NCPS: National Priority Contaminated Sites; 
AIRTUM: Italian Association of Cancer Registries. 
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graphical distribution, population size and years of ac-
tivity of each cancer registry. The observation period is 
1996-2005. In 5 out of 23 areas the number of years of 
observation is less than 10 years, ranging from 3 to 7.
The number of observed cases for all malignancies 
and specific cancer sites was compared to the expect-
ed figures based on age in 5-years period (18 classes), 
gender, period (1996-2000; 2001-2005), area (North-
Centre and Centre-South, not overlapping) and cancer 
sites specific rates. Two sets of geographical specific 
rates were calculated in light of a decreasing trend from 
north to south for the majority of cancer sites in Italy 
[11]. The populations from each NPCS and from two 
registries not participating to the study were excluded 
when calculating the expected. Standardized Incidence 
Ratios (SIRs) and 90% Confidence Intervals (90% CIs) 
were computed.
RESULTS
The overall study findings are reported in Table 1. 
In the overall analysis of 23 Italian contaminated sites 
served by cancer registries, on the basis of 57 391 and 49 
058 incident cases respectively among men and women, 
an excess of cancer incidence (9% in men and 7% in 
women) was observed. The excess of all malignant neo-
plasms present in both genders was mainly explained by 
malignant neoplasms of colon and rectum (in men and 
women respectively 7204 cases, 5% increase and 6460 
Table 1
Cancer incidence in National Priority Contaminated Sites (NPCSs) in Italy, 1996-2005
Men Women
ICD X – cancer site Observed SIR, 90% CI Observed SIR, 90% CI
Total (skin C44 excluded) Total, skin excluded 57391 1.09 1.08 1.1 49058 1.07 1.06 1.08
C15 Esophagus 697 1.22 1.14 1.29 230 1.24 1.11 1.38
C16 Stomach 2520 0.85 0.82 0.88 1932 0.84 0.81 0.88
C18-21 Colorectal 7204 1.05 1.03 1.07 6460 1.06 1.04 1.08
C22 Liver 3024 1.39 1.35 1.43 1419 1.32 1.26 1.37
C23-4  Gallbladder 589 1.12 1.04 1.19 951 1.12 1.06 1.18
C25   Pancreas 1543 1.12 1.08 1.17 1635 1.08 1.04 1.13
C32   Larynx 1575 1.19 1.14 1.24 193 1.43 1.27 1.61
C33-34  Lung 9396 1.07 1.05 1.09 3046 1.24 1.21 1.28
C40-41  Bone 104 0.97 0.82 1.14 94 1.04 0.87 1.23
C43   Skin melanoma 1280 1.24 1.18 1.29 1285 1.14 1.08 1.19
C45  Mesothelioma 469 1.88 1.74 2.03 110 1.11 0.94 1.3
C47,49  Connective and soft tissue 299 1.05 0.96 1.16 227 0.88 0.79 0.99
C47,49 (morphology codes) Soft tissue sarcoma 272 1.07 0.97 1.19 195 0.86 0.76 0.97
C50   Breast 117 0.98 0.84 1.14 14387 1.08 1.07 1.1
C53  Cervix 848 1.03 0.98 1.09
C54  Corpus uteri 2119 0.96 0.92 0.99
C53-55  Uterus 3173 1.00 0.97 1.03
C56   Ovary 1603 1.01 0.97 1.06
C61  Prostate 10481 1.13 1.11 1.15
C62  Testis 513 1.08 1.01 1.17
C64-66,8  Kidney and other urinary organs 2156 1.08 1.05 1.12 1222 1.08 1.03 1.13
C67-D09.0,D30.3,D41.4 Bladder, total 5872 1.05 1.03 1.08 1601 1.15 1.11 1.2
C70-72  Brain and central nervous system 915 1.07 1.02 1.13 791 1.05 0.99 1.11
C73  Thyroid 457 0.98 0.91 1.07 1399 0.89 0.85 0.93
C81-96  Lymphoemopoietic tissue 4345 1.01 0.98 1.04 4098 1.04 1.01 1.07
C81  Hodgkin lymphoma 319 1.00 0.91 1.1 297 1.08 0.98 1.19
C82-85,96  Non-Hodgkin lymphoma 1926 1.06 1.02 1.1 1866 1.07 1.03 1.11
C88,90  Multiple myeloma 732 1.03 0.97 1.09 749 1.03 0.97 1.09
C91-95  Leukemia 1368 0.95 0.91 0.99 1186 1.00 0.95 1.05
C91.0-C91.1 Lymphoid leukemia 585 0.89 0.83 0.96 488 0.95 0.88 1.02
C91.0 Acute lymphoid leukemia 133 0.93 0.8 1.08 121 1.04 0.89 1.21
C91.1 Chronic lymphoid leukemia 452 0.88 0.82 0.95 367 0.93 0.85 1.01
C92.0-C92.1 Myeloid leukemia 544 1.02 0.95 1.09 495 1.05 0.97 1.13
C92.0 Acute myeloid leukemia 340 1.00 0.91 1.1 310 0.98 0.89 1.08
C92.1  Chronic myeloid leukemia 204 1.04 0.93 1.17 185 1.17 1.04 1.33
Total (skin C44 excluded) Total, skin excluded 57391 1.09 1.08 1.1 49058 1.07 1.06 1.08
C15    Esophagus 697 1.22 1.14 1.29 230 1.24 1.11 1.38
a number of observed incident cases.
b SIR: Standardized Incidence Ratio, 90% CI: 90% Confidence Interval.
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cases 6% increase), liver (in men and women respec-
tively 3024 cases, 39% increase and 1419 cases 32% 
increase), gallbladder (in men and women respectively 
589 cases, 12% increase and 951 cases 12% increase), 
pancreas (in men and women respectively 1543 cases, 
12% increase and 1635 cases 8% increase), lung (in men 
and women respectively 9396 cases, 7% increase and 
3046 cases 24% increase), skin melanoma (in men and 
women respectively 1280 cases, 24% increase and 1285 
cases 14% increase), bladder (in men and women re-
spectively 5872 cases, 5% increase and 1601 cases 15% 
increase) and Non Hodgkin lymphoma (in men and 
women respectively 1926 cases, 6% increase and 1886 
cases 7% increase). Excesses of mesothelioma, and ma-
lignant neoplasms of prostate, testis, kidney and brain 
were present among men, among women increased 
incidence was present for breast cancer, lymphohae-
matopoietic system and in particular chronic myeloid 
leukemia. A deficit of gastric cancer was observed in 
both genders, deficits of total leukemias and specifically 
of (chronic) lymphoid leukemia were observed in men 
and, in women, deficits of malignant neoplasms of thy-
roid, corpus uteri and connective and soft-tissue tumours 
and sarcomas.
DISCUSSION
The assessment of the possible health impact of con-
taminated sites is a challenging issue, especially in the 
case of industrially contaminated sites involving multi-
ple and heterogeneous human exposures. The methods 
used in the SENTIERI Project has been defined by 
WHO as a first level approach to describe population 
health profiles in contaminated areas [1].
The present report is, to our knowledge, the first one 
on cancer risk of communities resident in areas defined 
as National Priority Contaminated Sites. The excess of 
cancer incidence in the pooled analysis confirmed the 
previous observation of cancer mortality excess in 44 
sites, 4.8% in men and 2.6% in women [4, 12].
Etiological hypotheses of a causal link between can-
cer incidence and residence in contaminated areas are 
present in the international scientific literature. There 
is general agreement, though, that an evaluation of suf-
ficient evidence of causality cannot be formulated, the 
exception being pleural mesothelioma and residence 
near asbestos mines or asbestos industries, such as as-
bestos-cement plants. Recently, increasing evidence has 
been provided for associations between residence near: 
i) processing and storage facilities and lung cancer and 
Non Hodgkin lymphoma [13, 14]; ii) refineries, ther-
mal power plants, steel and pulp mills and breast can-
cer [15]; iii) metal industries and prostate cancer [16] 
and digestive tract cancer [17]; iv) sites contaminated 
by toxic waste dumps and bladder and kidney cancer 
[18]. Increased incidence of haematological cancers, 
was observed in ZIP codes containing benzene waste 
sites [19]. A detailed review of this body of evidence has 
been recently published [20].
The present study did not aim to estimate the burden 
of tumours attributable to environmental exposures as 
compared to occupational exposures or life-style fac-
tors. However our results support the credibility of an 
etiologic role of environmental exposures, also in reason 
of several cancer excesses detected in both genders. 
Analytical studies, with improved exposure assessment, 
are needed to reach more firm conclusions. 
The plausibility of the observed cancer excesses is 
supported by their consistency with the a priori hypoth-
esized increases [3] and by the detailed report currently 
in press [21] on each of the 18 contaminated sites in-
cluded in the present article. 
In SENTIERI Project 90% CI were computed for 
risk estimators to present the range of uncertainty. Es-
timators were not accompanied by a hypothesis test to 
discriminate statistical significant from non statistical 
significant results. The choice of 90% level was made to 
minimize the acritical use of CI as surrogate of hypoth-
esis testing; such use could lead to consider relevant 
only those estimators for which the CI exclude the null 
value, i.e. the ones customarily defined as “statistical 
significant” [22, 23]. The discriminating use of statisti-
cal significance in the evaluation of causal associations 
in epidemiology has been discussed since 1965 [24] and 
recently re-proposed [25]. This is particularly the case 
in SENTIERI Project where an a priori evaluation of 
the epidemiological evidence was completed to identify 
those diseases for which the causal association with the 
environmental exposures was either ascertained or prob-
able. In SENTIERI the primary interest is on excesses 
or defects, i.e. direction of the risk estimators, and after 
on their size and precision, the latter inferred from the 
range of CI. 
The strengths of the present study are the validity of 
cancer registration and the elevated number of cases 
included in the investigation, which ensures a high 
statistical power. The quality indicators of AIRTUM 
registries comply with the international standards [6]. 
In addition, specific checks are routinely performed 
using also a software developed by AIRTUM (Check-
AIRTUM, www.registri-tumori.it). Furthermore, the 
selection of the study areas and the definition of a pri-
ori hypotheses has followed standardized and explicit 
criteria and procedures [3-5]. Major limitations of the 
investigation are the lack of a quantitative indicator of 
population exposure and the use of municipality as the 
smallest level of data aggregation. 
Another limitation is that risk estimates are not ad-
justed for potential confounders such as alcohol con-
sumption, smoking and socioeconomic status (SES), 
this last both positively and negatively associated with 
some cancers [3]. This lack of adjustment is most often 
the case in ecological studies. The overall estimates in 
the present paper were not adjusted for socioeconomic 
status (SES) although populations living in polluted ar-
eas have low SES [26]. This decision was based on a 
sensitivity analysis of ad hoc SENTIERI Deprivation In-
dex which did not show substantial differences between 
unadjusted and adjusted risk estimates. As far as smok-
ing and alcohol consumption are concerned, most can-
cer sites in excess have Sufficient or Limited evidence 
of association with tobacco or alcohol consumption [3]. 
There is no evidence that the environmental exposures in 
NPCSs are associated to either exposure, therefore the 
lack of adjustment should not lead to biased estimates. 
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Some underestimation of risk may derive from the in-
complete coverage of cancer registration in some NPC-
Ss. Developments of the multi-outcome SENTIERI 
approach include morbidity (as estimated by hospital 
discharge records), occurrence of congenital anomalies 
(pathology registries) and a specific focus on children 
health [27]. Ongoing analyses are focusing on the inter-
pretation of cancer incidence in single NPCS, in rela-
tion to industrial emissions and/or releases from dump-
ing sites as well as the presence of chemical carcinogens 
with evidence of association to specific tumours. Stud-
ies on the geographical distribution of cancer incidence 
based on individual data and environmental exposure 
modelling are also under way.
SENTIERI introduces a multiple outcome analytical 
model based on updated health outcomes in order to 
establish a permanent observation system to monitor 
the state of health of residents in contaminated areas. 
This will pave the way for more in-depth analytical epi-
demiological investigations and support the establish-
ment and continued monitoring of primary prevention 
projects. In SENTIERI particular attention is devoted 
to issues of information and communication.
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